US-based medical device giant Masimo Corporation expands its global footprint with the inauguration of a new production facility in the state of Johor, Malaysia, aimed at enhancing the manufacturing capacity of diagnostic tools for monitoring pulse rate and blood oxygen levels. Masimo Medical Technologies Malaysia, a subsidiary of Masimo, plans to invest MYR 100 million (USD 21 million) in this strategic move.
Masimo is set to construct a facility spanning 14,777 square meters in Pasir Gudang, Johor, housing a 9024 square meter production plant and a 5181 square meter warehouse. This expansion, capable of producing up to 100 million devices yearly, reflects Masimo’s dedication to meet the rising demand for top-quality medical equipment, capitalizing on Malaysia’s advantageous location and strong infrastructure.
The MedTech industry in Malaysia experiences robust growth, fostering a culture of innovation and attracting about 30 multinational companies engaged in various activities, from manufacturing to research and development. In 2023 alone, approved investments in the medical devices sector totaled MYR 2.17 billion (USD 450 million) across 26 projects. The Malaysian government’s unwavering support for the industry is evident through streamlined regulations and prioritization within Mission 1 of the New Industrial Master Plan 2030, aiming to position Malaysia as a leading hub for innovative manufacturing on the global stage.
(Sources: The Star; Investment Monitor)
